COVID-19 and atrial fibrillation: Intercepting lines
Almost 20% of COVID-19 patients have a history of atrial fibrillation (AF), but also a new-onset AF represents a frequent complication in COVID-19. Clinical evidence demonstrates that COVID-19, by promoting the evolution of a prothrombotic state, increases the susceptibility to arrhythmic events dur...
Main Authors: | Maria Donniacuo, Antonella De Angelis, Concetta Rafaniello, Eleonora Cianflone, Pasquale Paolisso, Daniele Torella, Gerolamo Sibilio, Giuseppe Paolisso, Giuseppe Castaldo, Konrad Urbanek, Francesco Rossi, Liberato Berrino, Donato Cappetta |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1093053/full |
Similar Items
-
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
by: Rosanna Ruggiero, et al.
Published: (2023-05-01) -
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
by: Maria Antonietta Riemma, et al.
Published: (2024-06-01) -
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021-04-01) -
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
by: Donato Cappetta, et al.
Published: (2021-08-01) -
Atrial Remodeling: Evolving Concepts
by: Mauro Biffi, et al.
Published: (2003-04-01)